Gut-associated IgA+ immune cells regulate obesity-related insulin resistance

Helen Luck; Saad Khan; Justin H. Kim; Julia K. Copeland; Xavier S. Revelo; Sue Tsai; Mainak Chakraborty; Kathleen Cheng; Yi Tao Chan; Mark K. Nøhr; Xavier Clemente-Casares; Marie Christine Perry; Magar Ghazarian; Helena Lei; Yi Hsuan Lin; Bryan Coburn; Allan Okrainec; Timothy Jackson; Susan Poutanen; Herbert Gaisano; Johane P. Allard; David S. Guttman; Margaret E. Conner; Shawn Winer; Daniel A. Winer

doi:10.1038/s41467-019-11370-y

Gut-associated IgA⁺ immune cells regulate obesity-related insulin resistance

Helen Luck, Saad Khan, Justin H. Kim, Julia K. Copeland, Xavier S. Revelo, Sue Tsai, Mainak Chakraborty, Kathleen Cheng, Yi Tao Chan, Mark K. Nøhr, Xavier Clemente-Casares, Marie Christine Perry, Magar Ghazarian, Helena Lei, Yi Hsuan Lin, Bryan Coburn, Allan Okrainec, Timothy Jackson, Susan Poutanen, Herbert GaisanoJohane P. Allard, David S. Guttman, Margaret E. Conner, Shawn Winer, Daniel A. Winer

Physiology

Research output: Contribution to journal › Article › peer-review

111 Scopus citations

Abstract

The intestinal immune system is emerging as an important contributor to obesity-related insulin resistance, but the role of intestinal B cells in this context is unclear. Here, we show that high fat diet (HFD) feeding alters intestinal IgA⁺ immune cells and that IgA is a critical immune regulator of glucose homeostasis. Obese mice have fewer IgA⁺ immune cells and less secretory IgA and IgA-promoting immune mediators. HFD-fed IgA-deficient mice have dysfunctional glucose metabolism, a phenotype that can be recapitulated by adoptive transfer of intestinal-associated pan-B cells. Mechanistically, IgA is a crucial link that controls intestinal and adipose tissue inflammation, intestinal permeability, microbial encroachment and the composition of the intestinal microbiome during HFD. Current glucose-lowering therapies, including metformin, affect intestinal-related IgA⁺ B cell populations in mice, while bariatric surgery regimen alters the level of fecal secretory IgA in humans. These findings identify intestinal IgA⁺ immune cells as mucosal mediators of whole-body glucose regulation in diet-induced metabolic disease.

Original language	English (US)
Article number	3650
Journal	Nature communications
Volume	10
Issue number	1
DOIs	https://doi.org/10.1038/s41467-019-11370-y
State	Published - Dec 1 2019

Bibliographical note

Funding Information:
We would like to kindly thank CAGEF at the University of Toronto for the gut microbiota sequencing, STTARR facility for the immunohistochemistry work, and Maryam Alghamdi, Carrie Li, Fariba Abedi, Monica L. Ponta, Aimee Paterson, and Melissa Kissoon for their work related to the bariatric human data, including study setup, patient screening, recruitment, visits, data and sample collections, and processing. This work is supported in part by Canadian Institutes of Health Research (CIHR) grants 119414, 142708, and 148385 (D.A.W.), Diabetes Canada grant OG-3-15-5014 (D.A.W.), and the Canadian Liver Foundation (CLF) (2017 operating grant). The bariatric surgery research is supported by CIHR 303157 and UTRS 152465. D.A.W. is a recipient of a Canada Research Chair, and the Ontario Ministry of Innovation Early Researcher Award. S.K. is a recipient of the Queen Elizabeth II Graduate Scholarship in Science and Technology (QEII-GSST)/Aventis Pasteur, and the Banting and Best Diabetes Centre (BBDC) Graduate Scholarship. H.L. is a recipient of the CIHR Canada Graduate Scholarship-Doctoral (CGS-D) Award.

Publisher Copyright:
© 2019, The Author(s).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1038/s41467-019-11370-y

Find It

Find It at U of M Libraries

Cite this

Luck, H., Khan, S., Kim, J. H., Copeland, J. K., Revelo, X. S., Tsai, S., Chakraborty, M., Cheng, K., Tao Chan, Y., Nøhr, M. K., Clemente-Casares, X., Perry, M. C., Ghazarian, M., Lei, H., Lin, Y. H., Coburn, B., Okrainec, A., Jackson, T., Poutanen, S., ... Winer, D. A. (2019). Gut-associated IgA⁺ immune cells regulate obesity-related insulin resistance. Nature communications, 10(1), Article 3650. https://doi.org/10.1038/s41467-019-11370-y

Luck, H, Khan, S, Kim, JH, Copeland, JK, Revelo, XS, Tsai, S, Chakraborty, M, Cheng, K, Tao Chan, Y, Nøhr, MK, Clemente-Casares, X, Perry, MC, Ghazarian, M, Lei, H, Lin, YH, Coburn, B, Okrainec, A, Jackson, T, Poutanen, S, Gaisano, H, Allard, JP, Guttman, DS, Conner, ME, Winer, S & Winer, DA 2019, 'Gut-associated IgA⁺ immune cells regulate obesity-related insulin resistance', Nature communications, vol. 10, no. 1, 3650. https://doi.org/10.1038/s41467-019-11370-y

@article{c124608ec49e4e6b95f1d819c540dc11,

title = "Gut-associated IgA+ immune cells regulate obesity-related insulin resistance",

abstract = "The intestinal immune system is emerging as an important contributor to obesity-related insulin resistance, but the role of intestinal B cells in this context is unclear. Here, we show that high fat diet (HFD) feeding alters intestinal IgA+ immune cells and that IgA is a critical immune regulator of glucose homeostasis. Obese mice have fewer IgA+ immune cells and less secretory IgA and IgA-promoting immune mediators. HFD-fed IgA-deficient mice have dysfunctional glucose metabolism, a phenotype that can be recapitulated by adoptive transfer of intestinal-associated pan-B cells. Mechanistically, IgA is a crucial link that controls intestinal and adipose tissue inflammation, intestinal permeability, microbial encroachment and the composition of the intestinal microbiome during HFD. Current glucose-lowering therapies, including metformin, affect intestinal-related IgA+ B cell populations in mice, while bariatric surgery regimen alters the level of fecal secretory IgA in humans. These findings identify intestinal IgA+ immune cells as mucosal mediators of whole-body glucose regulation in diet-induced metabolic disease.",

author = "Helen Luck and Saad Khan and Kim, {Justin H.} and Copeland, {Julia K.} and Revelo, {Xavier S.} and Sue Tsai and Mainak Chakraborty and Kathleen Cheng and {Tao Chan}, Yi and N{\o}hr, {Mark K.} and Xavier Clemente-Casares and Perry, {Marie Christine} and Magar Ghazarian and Helena Lei and Lin, {Yi Hsuan} and Bryan Coburn and Allan Okrainec and Timothy Jackson and Susan Poutanen and Herbert Gaisano and Allard, {Johane P.} and Guttman, {David S.} and Conner, {Margaret E.} and Shawn Winer and Winer, {Daniel A.}",

note = "Funding Information: We would like to kindly thank CAGEF at the University of Toronto for the gut microbiota sequencing, STTARR facility for the immunohistochemistry work, and Maryam Alghamdi, Carrie Li, Fariba Abedi, Monica L. Ponta, Aimee Paterson, and Melissa Kissoon for their work related to the bariatric human data, including study setup, patient screening, recruitment, visits, data and sample collections, and processing. This work is supported in part by Canadian Institutes of Health Research (CIHR) grants 119414, 142708, and 148385 (D.A.W.), Diabetes Canada grant OG-3-15-5014 (D.A.W.), and the Canadian Liver Foundation (CLF) (2017 operating grant). The bariatric surgery research is supported by CIHR 303157 and UTRS 152465. D.A.W. is a recipient of a Canada Research Chair, and the Ontario Ministry of Innovation Early Researcher Award. S.K. is a recipient of the Queen Elizabeth II Graduate Scholarship in Science and Technology (QEII-GSST)/Aventis Pasteur, and the Banting and Best Diabetes Centre (BBDC) Graduate Scholarship. H.L. is a recipient of the CIHR Canada Graduate Scholarship-Doctoral (CGS-D) Award. Publisher Copyright: {\textcopyright} 2019, The Author(s).",

year = "2019",

month = dec,

day = "1",

doi = "10.1038/s41467-019-11370-y",

language = "English (US)",

volume = "10",

journal = "Nature communications",

issn = "2041-1723",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Gut-associated IgA+ immune cells regulate obesity-related insulin resistance

AU - Luck, Helen

AU - Khan, Saad

AU - Kim, Justin H.

AU - Copeland, Julia K.

AU - Revelo, Xavier S.

AU - Tsai, Sue

AU - Chakraborty, Mainak

AU - Cheng, Kathleen

AU - Tao Chan, Yi

AU - Nøhr, Mark K.

AU - Clemente-Casares, Xavier

AU - Perry, Marie Christine

AU - Ghazarian, Magar

AU - Lei, Helena

AU - Lin, Yi Hsuan

AU - Coburn, Bryan

AU - Okrainec, Allan

AU - Jackson, Timothy

AU - Poutanen, Susan

AU - Gaisano, Herbert

AU - Allard, Johane P.

AU - Guttman, David S.

AU - Conner, Margaret E.

AU - Winer, Shawn

AU - Winer, Daniel A.

N1 - Funding Information: We would like to kindly thank CAGEF at the University of Toronto for the gut microbiota sequencing, STTARR facility for the immunohistochemistry work, and Maryam Alghamdi, Carrie Li, Fariba Abedi, Monica L. Ponta, Aimee Paterson, and Melissa Kissoon for their work related to the bariatric human data, including study setup, patient screening, recruitment, visits, data and sample collections, and processing. This work is supported in part by Canadian Institutes of Health Research (CIHR) grants 119414, 142708, and 148385 (D.A.W.), Diabetes Canada grant OG-3-15-5014 (D.A.W.), and the Canadian Liver Foundation (CLF) (2017 operating grant). The bariatric surgery research is supported by CIHR 303157 and UTRS 152465. D.A.W. is a recipient of a Canada Research Chair, and the Ontario Ministry of Innovation Early Researcher Award. S.K. is a recipient of the Queen Elizabeth II Graduate Scholarship in Science and Technology (QEII-GSST)/Aventis Pasteur, and the Banting and Best Diabetes Centre (BBDC) Graduate Scholarship. H.L. is a recipient of the CIHR Canada Graduate Scholarship-Doctoral (CGS-D) Award. Publisher Copyright: © 2019, The Author(s).

PY - 2019/12/1

Y1 - 2019/12/1

N2 - The intestinal immune system is emerging as an important contributor to obesity-related insulin resistance, but the role of intestinal B cells in this context is unclear. Here, we show that high fat diet (HFD) feeding alters intestinal IgA+ immune cells and that IgA is a critical immune regulator of glucose homeostasis. Obese mice have fewer IgA+ immune cells and less secretory IgA and IgA-promoting immune mediators. HFD-fed IgA-deficient mice have dysfunctional glucose metabolism, a phenotype that can be recapitulated by adoptive transfer of intestinal-associated pan-B cells. Mechanistically, IgA is a crucial link that controls intestinal and adipose tissue inflammation, intestinal permeability, microbial encroachment and the composition of the intestinal microbiome during HFD. Current glucose-lowering therapies, including metformin, affect intestinal-related IgA+ B cell populations in mice, while bariatric surgery regimen alters the level of fecal secretory IgA in humans. These findings identify intestinal IgA+ immune cells as mucosal mediators of whole-body glucose regulation in diet-induced metabolic disease.

AB - The intestinal immune system is emerging as an important contributor to obesity-related insulin resistance, but the role of intestinal B cells in this context is unclear. Here, we show that high fat diet (HFD) feeding alters intestinal IgA+ immune cells and that IgA is a critical immune regulator of glucose homeostasis. Obese mice have fewer IgA+ immune cells and less secretory IgA and IgA-promoting immune mediators. HFD-fed IgA-deficient mice have dysfunctional glucose metabolism, a phenotype that can be recapitulated by adoptive transfer of intestinal-associated pan-B cells. Mechanistically, IgA is a crucial link that controls intestinal and adipose tissue inflammation, intestinal permeability, microbial encroachment and the composition of the intestinal microbiome during HFD. Current glucose-lowering therapies, including metformin, affect intestinal-related IgA+ B cell populations in mice, while bariatric surgery regimen alters the level of fecal secretory IgA in humans. These findings identify intestinal IgA+ immune cells as mucosal mediators of whole-body glucose regulation in diet-induced metabolic disease.

UR - http://www.scopus.com/inward/record.url?scp=85070747347&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070747347&partnerID=8YFLogxK

U2 - 10.1038/s41467-019-11370-y

DO - 10.1038/s41467-019-11370-y

M3 - Article

C2 - 31409776

AN - SCOPUS:85070747347

SN - 2041-1723

VL - 10

JO - Nature communications

JF - Nature communications

IS - 1

M1 - 3650

ER -